Servicios de PI
Sobre la PI
34, chemin des Colombettes
CH-1211 Ginebra 20, Suiza
Visite la OMPI |
La OMPI por dentro
Consulta > Inglés > 2015 > Current
Strategic Review of WIPO Re:Search
Global Challenges Report
WIPO Re:Search was established in 2011 and has enjoyed more than three years of progress and success. The current report explores ways to secure the longer-term success and sustainability of WIPO Re:Search through the expansion of its programs and additional support. The Consortium, an initiative of the World Intellectual Property Organization (WIPO), which hosts the WIPO Re:Search secretariat is managed jointly with BIO Ventures for Global Health (BVGH) (Seattle, USA) which operates the WIPO Re:Search Partnership Hub.
Año de publicación: 2015
Geneva Act of the Lisbon Agreement on Appellations of Origin and Geographical Indications
The Geneva Act allows the international registration of geographical indications (GIs), in addition to appellations of origin, and permits the accession to the Lisbon Agreement by certain intergovernmental organizations.
Global Innovation Index 2015
Effective Innovation Policies for Development
The Global Innovation Index ranks the innovation performance of 141 countries and economies around the world, based on 79 indicators. This edition explores the impact of innovation-oriented policies on economic growth and development. High-income and developing countries alike are seeking innovation-driven growth through different strategies. Some countries are successfully improving their innovation capacity, while others still struggle.
WIPO Re:Search: Sharing Innovation in the Fight Against Neglected Tropical Diseases
Global Challenges Brief
An overview of issues relevant to debates about solutions to global challenges, such as climate change, public health and food security.
Private International Law Issues in Online Intellectual Property Infringement Disputes with Cross-Border Elements
An Analysis of National Approaches
The objective of this report is to contribute to the understanding of the issues at the interface between private international law and intellectual property through an empirical study, and to identify possible future activities in this area.
Sources of Biopharmaceutical Innovation: An Assessment of Intellectual Property
Economic Research Working Paper No. 24
An analysis of new, FDA-approved molecular entities reveals dynamism in terms of new innovation. An assessment of the first patent for each drug reveals that the pharmaceutical industry, particularly large, established companies in North America, tend to dominate the field. Whereas inventors continue to found biotechnology companies at a steady rate, recent trends suggest these inventors more often come from the private sector.
World Intellectual Property Report 2015 - Breakthrough Innovation and Economic Growth
WIPO's latest World Intellectual Property Report (WIPR) explores the role of IP at the nexus of innovation and economic growth, focusing on the impact of breakthrough innovations.
Guidelines for Preparing Patent Landscape Reports
These Guidelines are designed both for general users of patent information, as well as for those involved in producing Patent Landscape Reports (PLRs). They provide step-by-step instructions on how to prepare a PLR, as well as background information such as objectives, patent analytics, concepts and frameworks.
Patent Landscape Report on Assistive Devices and Technologies for Visually and Hearing Impaired Persons
This is the first report of the WIPO Patent Landscape Report series in the area of disabilities. It presents research on various assistive devices and technologies, includes an analysis on the geographical distribution of patent protection of these technologies, and features business data on major patent portfolios as well as a round-up of key innovators. Additionally, the report touches on technologies serving the same goals as the Marrakesh Treaty and the Accessible Book Consortium (ABC), namely those facilitating access of visually and hearing impaired persons to published works.